Laser zaps face veins in scleroderma patients – 21 test it out
NCT ID NCT05036200
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a pulsed dye laser to reduce red veins (telangiectasias) on the face and neck in 21 people with scleroderma. Participants received four laser sessions, and the researchers checked how many veins disappeared, how patients felt about the results, and any side effects. The goal was to see if the laser is a safe and helpful option for improving appearance and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLERODERMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chu Caen Normandie
Caen, Normandy, 14000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive HHT registry aims to unlock secrets of rare bleeding disorder
- New antibody drug aims to halt Scleroderma's grip
- Tiny particles may hold clues to autoimmune diseases
- Can a viagra drug heal scleroderma finger sores?
- Could a single infusion of supercharged immune cells tame incurable autoimmune diseases?
- New antibody drug firsekibart tested for scleroderma skin thickening